Introduction: Many types of research have been performed to improve the diagnosis, therapy, and prognosis of oropharyngeal carcinomas (OP-SCCs). Since they arise in lymphoid-rich areas and intense lymphocytic infiltration has been related to a better prognosis, a TREM-1 putative function in tumour progression and survival has been hypothesized. Materials and methods: Twenty-seven human papillomavirus (HPV) 16+ OP-SCC specimens have been analyzed to relate TREM-1 expression with histiocytic and lymphocytic markers, HPV presence and patients’ outcome. Results: No differences have been shown between intratumoral and stromal CD4+ cells, while intratumoral CD8+ lymphocytes are higher with respect to the tumour stroma (p=.0005). CD68+ cells are more than CD35+ and TREM-1+; their presence is related to CD35± and TREM-1± histiocytes (p=.005 and.026, respectively). Intratumoral CD4+ lymphocytes are higher in p16+ cases (11/27) than in p16− (p=.042); moreover, p16 positivity correlates to a better survival (p=.034). CD4+, CD8+ and CD35+ cells have no impact on survival, while CD68 expression heavily influences progression and bad outcome (p=.037). TREM-1 positivity also leads to worst overall survival (p=.001): peritumoral expression and death-cause relationship are always significant, particularly when the cause is OP-SCC (p=.000). Conclusion: While p16 shows to better stratify HPV16+ patients’ outcome, TREM-1+ macrophages suggest their key importance in HPV-related OP-SCCs progression.KEY MESSAGES TREM-1 positivity correlates to the worst overall survival of HPV16-positive OPSCCs-affected patients. p16-positive HPV16 related OPSCCs patients have a better prognosis with respect to p16-negative ones.

Macrophages expressing TREM-1 are involved in the progression of HPV16-related oropharyngeal squamous cell carcinoma / B. Azzimonti, L. Raimondo, D.F. Squarzanti, T. Rosso, P. Zanetta, P. Aluffi Valletti, L. Chiusa, L. Masini, G. Pecorari, M. Airoldi, M. Krengli, M. Giovarelli, G. Valente. - In: ANNALS OF MEDICINE. - ISSN 0785-3890. - 53:1(2021), pp. 541-550. [10.1080/07853890.2021.1905872]

Macrophages expressing TREM-1 are involved in the progression of HPV16-related oropharyngeal squamous cell carcinoma

D.F. Squarzanti;
2021

Abstract

Introduction: Many types of research have been performed to improve the diagnosis, therapy, and prognosis of oropharyngeal carcinomas (OP-SCCs). Since they arise in lymphoid-rich areas and intense lymphocytic infiltration has been related to a better prognosis, a TREM-1 putative function in tumour progression and survival has been hypothesized. Materials and methods: Twenty-seven human papillomavirus (HPV) 16+ OP-SCC specimens have been analyzed to relate TREM-1 expression with histiocytic and lymphocytic markers, HPV presence and patients’ outcome. Results: No differences have been shown between intratumoral and stromal CD4+ cells, while intratumoral CD8+ lymphocytes are higher with respect to the tumour stroma (p=.0005). CD68+ cells are more than CD35+ and TREM-1+; their presence is related to CD35± and TREM-1± histiocytes (p=.005 and.026, respectively). Intratumoral CD4+ lymphocytes are higher in p16+ cases (11/27) than in p16− (p=.042); moreover, p16 positivity correlates to a better survival (p=.034). CD4+, CD8+ and CD35+ cells have no impact on survival, while CD68 expression heavily influences progression and bad outcome (p=.037). TREM-1 positivity also leads to worst overall survival (p=.001): peritumoral expression and death-cause relationship are always significant, particularly when the cause is OP-SCC (p=.000). Conclusion: While p16 shows to better stratify HPV16+ patients’ outcome, TREM-1+ macrophages suggest their key importance in HPV-related OP-SCCs progression.KEY MESSAGES TREM-1 positivity correlates to the worst overall survival of HPV16-positive OPSCCs-affected patients. p16-positive HPV16 related OPSCCs patients have a better prognosis with respect to p16-negative ones.
Human papillomavirus (HPV); oropharyngeal squamous cell carcinoma (OP-SCCs); peritumoral and intratumoral infiltration; triggering receptor expressed on myeloid cells-1 (TREM-1); tumoral microenvironment (TME)
Settore MEDS-09/A - Oncologia medica
2021
Article (author)
File in questo prodotto:
File Dimensione Formato  
IANN_53_1905872.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Licenza: Creative commons
Dimensione 2.2 MB
Formato Adobe PDF
2.2 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1236317
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 7
  • OpenAlex 7
social impact